The data presented here showing a synergistic inhibitory effect on tumor growth by ACSL4, LOX-5 and COX-2 inhibitors with the use of lower doses of the respective drugs may also result in the reduction of potentially severe side-effects. Here, ACSL4 is linked to neoplasm.